<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489460</url>
  </required_header>
  <id_info>
    <org_study_id>17-01591</org_study_id>
    <nct_id>NCT03489460</nct_id>
  </id_info>
  <brief_title>Research Exploring Sleep Education &amp; Technology</brief_title>
  <acronym>RESET</acronym>
  <official_title>Research Exploring Sleep Education &amp; Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot study that seeks to develop a set of typologies of users of mobile sleep tracking
      technologies, and optimal sleep health educational strategies among users of mobile wearable
      technologies that track sleep.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">August 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep time measured by wearable mobile sleep tracking technology</measure>
    <time_frame>15 Days</time_frame>
    <description>Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time in deep sleep measured by wearable mobile sleep tracking technology</measure>
    <time_frame>15 Days</time_frame>
    <description>Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dysfunctional Beliefs about Sleep (DBAS) scale</measure>
    <time_frame>1 Day</time_frame>
    <description>24-item DBAS scale with five subscales corresponding to: (1) consequences of insomnia (2) control and predictability of sleep (3) sleep requirement expectations (5) sleep-promoting practices</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure of motivation to change using the Change Assessment Scale (CAS)</measure>
    <time_frame>15 Days</time_frame>
    <description>8 scale measure divided into 4 separate scales: Scale 1: &quot;Pre-Contemplation&quot; Scale 2: &quot;Contemplation&quot; Scale 3 &quot;Action&quot; Scale 4 &quot;Maintenance&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1060</enrollment>
  <condition>Sleep Health</condition>
  <arm_group>
    <arm_group_label>Receive sleep health messages + GAD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedures will be delivered to users of the GAD, individuals who have opted in via their smartphone application, to receive messages about various areas of health.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleep message No GAD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For two weeks participants agree to receive sleep health messages and wear the GAD</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Specialized sleep-related message interventions</intervention_name>
    <description>Over the course of 2 weeks' participants will receive specialized sleep-related message interventions to encourage sleep awareness via the smartphone application.</description>
    <arm_group_label>Receive sleep health messages + GAD</arm_group_label>
    <arm_group_label>Sleep message No GAD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>GAD</intervention_name>
    <description>Survey responses will be merged with objective GAD data (sleep time, time in deep sleep, physical activity) which will assist in developing message design formats for message testing.</description>
    <arm_group_label>Receive sleep health messages + GAD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A current user of the OURA ring activity and sleep tracker device.

        For Aim 3 MOST message testing, the inclusion criteria include the following:

          -  Health conscious.

        Exclusion Criteria:

          -  Non English speakers.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Girardin Jean-Louis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sleep health</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Immediately following publication. No end date</ipd_time_frame>
    <ipd_access_criteria>Requests should be directed to Rebecca.robbins@nyulangone.org. To gain access, data requestors will need to sign a data access agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

